Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 331 | 207 | 900 | 1,105 | 454 |
| Marketable Securities | 23 | 28 | 38 | 25 | N/A |
| Receivables | 56 | 37 | 12 | 41 | 87 |
| Inventories | 640 | 638 | 640 | 658 | 1,349 |
| Other current assets | 214 | 237 | 200 | 175 | 263 |
| TOTAL | $1,264 | $1,147 | $1,790 | $2,004 | $2,153 |
| Non-Current Assets | |||||
| PPE Net | 2,069 | 2,103 | 2,141 | 2,175 | 3,097 |
| Intangibles | 5,507 | 5,268 | 5,101 | 4,879 | 1,997 |
| Other Non-Current Assets | 656 | 667 | 680 | 685 | 696 |
| TOTAL | $8,232 | $8,038 | $7,922 | $7,739 | $5,790 |
| Total Assets | $9,496 | $9,185 | $9,712 | $9,743 | $7,943 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 933 | 726 | 180 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,618 | 1,255 | 1,014 | 628 | 933 |
| Accrued Expenses | 664 | 892 | 962 | 886 | 792 |
| TOTAL | $3,215 | $2,873 | $2,156 | $1,514 | $1,725 |
| Non-Current Liabilities | |||||
| Long Term Debt | 149 | 191 | 131 | 132 | 133 |
| Other Non-Current Liabilities | 0 | 0 | 2 | 5 | 7 |
| TOTAL | $149 | $191 | $133 | $137 | $140 |
| Total Liabilities | $3,364 | $3,064 | $2,289 | $1,651 | $1,865 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 103,384 | 100,091 | N/A | 92,868 | 90,809 |
| Common Shares | 142,065 | 139,122 | 138,014 | 135,774 | 131,920 |
| Retained earnings | -130,228 | -127,292 | -124,890 | -122,828 | -122,343 |
| Other shareholders' equity | -5,705 | -5,709 | -5,701 | -4,854 | -3,499 |
| TOTAL | $6,132 | $6,121 | $7,423 | $8,092 | $6,078 |
| Total Liabilities And Equity | $9,496 | $9,185 | $9,712 | $9,743 | $7,943 |